LFCR · Lifecore Biomedical, Inc. \De\

$4.39 +0.05 (+1.15%) At close · Jul 28

Market Cap

$162.79M

37.51M

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized

$3,800,000

as of 2023-02-26 · not restated in filings since 2023-06-02

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended	Cash Spent	Shares	Avg Price	Source
2012-05-27	$5,006,000	917,244	—	10-K, filed 2014-08-01
2011-05-29	$1,184,000	215,684	—	10-K, filed 2013-08-07

Quarter Ended	Cash Spent	Shares	Avg Price	Source
2012-02-26	$202,000 Δ	—	—	10-Q, filed 2013-04-04
2011-05-29	$0 Δ	—	—	10-K, filed 2013-08-07
2010-08-29	$362,000	—	—	10-Q, filed 2011-10-05

Key facts CIK 1005286 CUSIP 514766104 13F (30d) 16 filings 16 filers Visit website Investor relations